NSABP FC-10: Phase IB study of pembrolizumab in combination with premetrexed plus oaliplatin in patients (pts) with chemo-refractory metastatic colorectal cancer (mCRC)

Lee, JJ; Yothers, G; George, TJ; Krauss, JC; Maalouf, BN; Parekh, HD; Krishnamurthy, A; Vehec, KR; Wolmark, N; Allegra, CJ; Jacobs, SA

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):